Dr. Jonathan Kay discusses the big questions surrounding biosimilar medications in rheumatology: Are they safe and effective, and can they be interchanged with the reference compound?

A look at the FDA's recent and controversial opioid analgesic approval.

Does adding fish oil to DMARD therapy provide benefit in patients with rheumatoid arthritis?

Touching on data presented at the American College of Rheumatology 2013 Annual Meeting, Dr. Jonathan Kay discusses the benefits and drawbacks of triple therapy in rheumatoid arthritis.

Some doctors wonder whether it's wise to apologize if they've made an error. Bioethicist Art Caplan says it's a good idea, but you need to do it the right way.

Dr. Atul Gawande talks with Dr. Eric Topol about being mesmerized by surgery, unpeeling great stories, and why he keeps his options open.

Nearly 2 decades after the furor over Lucian Leape's 'Error in Medicine,' the number of hospital deaths related to medical errors continues to grow.

A 29-year-old Stanford dropout has developed a new biotechnology that threatens to give laboratory medicine its biggest shakeup in decades.

Dr. Eric Topol talks with NBC's Dr. Nancy Snyderman about juggling careers in medicine and television, and what it's like to break through academia's glass ceiling.

FDA Commissioner Margaret Hamburg, MD, talks with Medscape at the National Health Research Forum in Washington, DC.